{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:19:21Z","timestamp":1788520761477,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["10894"],"award-info":[{"award-number":["10894"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["11079"],"award-info":[{"award-number":["11079"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oncode"},{"DOI":"10.13039\/501100010890","name":"CSC | Chinese Government Scholarship","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Whether a T-cell response to dead cells arises depends on whether they harbor recognizable antigens, but also how dead cell debris impacts conventional dendritic cells (cDCs). In all tissues, cell debris is continuously phagocytosed by cDCs that can migrate to lymph nodes (LNs) and initiate T-cell responses, depending on their maturation state. The cDC1 lineage excels at antigen cross-presentation, which is required for induction of the CD8\n                    <jats:sup>+<\/jats:sup>\n                    cytotoxic\u00a0T-lymphocyte (CTL) response. At steady state, cDC1s undergo homeostatic maturation, which leads to T-cell non-responsiveness. This cDC1 state has recently been defined by ex vivo transcriptomics as resulting from phagocytosis of apoptotic cell debris. Necroptotic (tumor) cell death has been described as more immunogenic than apoptotic cell death, but its impact on cDC maturation has not been defined. In this study, we use an in vitro model to compare side-by-side the impact of well-defined apoptotic versus necroptotic tumor cell debris on the CTL response induced by cDCs, as well as on phenotype and function of both cDC1s and cDC2s. We confirm that cDC2s are less efficient than cDC1s in dead cell phagocytosis and find that they minimally respond to it in terms of gene expression. Apoptotic cell debris is more efficiently phagocytosed by cDC1s than necroptotic cell debris and induces a cDC1 cell state in vitro that has an evident transcriptomic relationship to the homeostatic maturation state defined ex vivo, thus validating our approach. We identify necroptosis as more potent than apoptosis in inducing a CTL response and attribute this to the ability of necroptotic cell debris to induce a specific, transcriptomically defined maturation state in cDC1s, characterized by cytokine and phosphoinositide signaling, cytoskeletal and metabolic activity and functional differentiation. We suggest that this cDC1 signature may be used to diagnose immunogenicity of necroptosis ex vivo.\n                  <\/jats:p>","DOI":"10.1038\/s41418-026-01689-7","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T14:36:45Z","timestamp":1772289405000},"page":"1768-1782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phagocytosis of necroptotic cells optimizes type 1 conventional dendritic cells for induction of a cytotoxic T-cell response"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8568-6248","authenticated-orcid":false,"given":"Mo D.","family":"Staal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3862-1239","authenticated-orcid":false,"given":"Zhixian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3500-8649","authenticated-orcid":false,"given":"Douwe M. T.","family":"Bosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2402-4245","authenticated-orcid":false,"given":"Julia","family":"Busselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Schrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evert","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1755-1709","authenticated-orcid":false,"given":"Yanling","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8043-5009","authenticated-orcid":false,"given":"Jannie","family":"Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"1689_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","volume":"24","author":"P Meier","year":"2024","unstructured":"Meier P, Legrand AJ, Adam D, Silke J. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Nat Rev Cancer. 2024;24:299\u2013315.","journal-title":"Nat Rev Cancer"},{"key":"1689_CR2","doi-asserted-by":"crossref","unstructured":"Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. J Immunother Cancer. 2020;8:e000337.","DOI":"10.1136\/jitc-2019-000337corr1"},{"key":"1689_CR3","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman I, Chen DS, Powles T, Turley SJ. The cancer-immunity cycle: Indication, genotype, and immunotype. Immunity. 2023;56:2188\u2013205.","journal-title":"Immunity"},{"key":"1689_CR4","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","volume":"56","author":"MJ Pittet","year":"2023","unstructured":"Pittet MJ, Di Pilato M, Garris C, Mempel TR. Dendritic cells as shepherds of T cell immunity in cancer. Immunity. 2023;56:2218\u201330.","journal-title":"Immunity"},{"key":"1689_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","volume":"18","author":"J Borst","year":"2018","unstructured":"Borst J, Ahrends T, Babala N, Melief CJM, Kastenmuller W. CD4(+) T cell help in cancer immunology and immunotherapy. Nat Rev Immunol. 2018;18:635\u201347.","journal-title":"Nat Rev Immunol"},{"key":"1689_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/imr.13301","volume":"321","author":"S Janssens","year":"2024","unstructured":"Janssens S, Rennen S, Agostinis P. Decoding immunogenic cell death from a dendritic cell perspective. Immunol Rev. 2024;321:350\u201370.","journal-title":"Immunol Rev"},{"key":"1689_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102350","volume":"83","author":"RA Ohara","year":"2023","unstructured":"Ohara RA, Murphy KM. Recent progress in type 1 classical dendritic cell cross-presentation - cytosolic, vacuolar, or both? Curr Opin Immunol. 2023;83:102350.","journal-title":"Curr Opin Immunol"},{"key":"1689_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","volume":"19","author":"SC Eisenbarth","year":"2019","unstructured":"Eisenbarth SC. Dendritic cell subsets in T cell programming: location dictates function. Nat Rev Immunol. 2019;19:89\u2013103.","journal-title":"Nat Rev Immunol"},{"key":"1689_CR9","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg MEW, Scheeren FA, Schumacher TN. The CD47-SIRPalpha Immune Checkpoint. Immunity. 2020;52:742\u201352.","journal-title":"Immunity"},{"key":"1689_CR10","doi-asserted-by":"crossref","unstructured":"van Duijn A, Van der Burg SH, Scheeren FA. CD47\/SIRPalpha axis: bridging innate and adaptive immunity. J Immunother Cancer. 2022;10:e004589.","DOI":"10.1136\/jitc-2022-004589"},{"key":"1689_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","volume":"39","author":"M Cabeza-Cabrerizo","year":"2021","unstructured":"Cabeza-Cabrerizo M, Cardoso A, Minutti CM, Pereira da Costa M, Reis e Sousa C. Dendritic Cells Revisited. Annu Rev Immunol. 2021;39:131\u201366.","journal-title":"Annu Rev Immunol"},{"key":"1689_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add3955","volume":"8","author":"V Bosteels","year":"2023","unstructured":"Bosteels V, Marechal S, De Nolf C, Rennen S, Maelfait J, Tavernier SJ, et al. LXR signaling controls homeostatic dendritic cell maturation. Sci Immunol. 2023;8:eadd3955.","journal-title":"Sci Immunol"},{"key":"1689_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.immuni.2016.07.019","volume":"45","author":"L Ardouin","year":"2016","unstructured":"Ardouin L, Luche H, Chelbi R, Carpentier S, Shawket A, Montanana Sanchis F, et al. Broad and Largely Concordant Molecular Changes Characterize Tolerogenic and Immunogenic Dendritic Cell Maturation in Thymus and Periphery. Immunity. 2016;45:305\u201318.","journal-title":"Immunity"},{"key":"1689_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature16169","volume":"528","author":"Z Liu","year":"2015","unstructured":"Liu Z, Gerner MY, Van Panhuys N, Levine AG, Rudensky AY, Germain RN. Immune homeostasis enforced by co-localized effector and regulatory T cells. Nature. 2015;528:225\u201330.","journal-title":"Nature"},{"key":"1689_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan J, Ofengeim D. A guide to cell death pathways. Nat Rev Mol Cell Biol. 2024;25:379\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1689_CR16","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1016\/j.molcel.2025.09.007","volume":"85","author":"R Chen","year":"2025","unstructured":"Chen R, Zou J, Liu J, Kang R, Tang D. DAMPs in the immunogenicity of cell death. Mol Cell. 2025;85:3874\u201389.","journal-title":"Mol Cell"},{"key":"1689_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.trecan.2023.02.001","volume":"9","author":"K Hanggi","year":"2023","unstructured":"Hanggi K, Ruffell B. Cell death, therapeutics, and the immune response in cancer. Trends Cancer. 2023;9:381\u201396.","journal-title":"Trends Cancer"},{"key":"1689_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","volume":"23","author":"G Kroemer","year":"2022","unstructured":"Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol. 2022;23:487\u2013500.","journal-title":"Nat Immunol"},{"key":"1689_CR19","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.celrep.2019.12.079","volume":"30","author":"MC Tanzer","year":"2020","unstructured":"Tanzer MC, Frauenstein A, Stafford CA, Phulphagar K, Mann M, Meissner F. Quantitative and Dynamic Catalogs of Proteins Released during Apoptotic and Necroptotic Cell Death. Cell Rep. 2020;30:1260\u201370.e5.","journal-title":"Cell Rep"},{"key":"1689_CR20","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1038\/s41590-025-02298-1","volume":"26","author":"JE Vince","year":"2025","unstructured":"Vince JE, Davidson NM, Tanzer MC. Necroptotic cell death consequences and disease relevance. Nat Immunol. 2025;26:1863\u201376.","journal-title":"Nat Immunol"},{"key":"1689_CR21","doi-asserted-by":"crossref","unstructured":"Ovcinnikovs V, Ross EM, Petersone L, Edner NM, Heuts F, Ntavli E, et al. CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells. Sci Immunol. 2019;4:eaaw0902.","DOI":"10.1126\/sciimmunol.aaw0902"},{"key":"1689_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun L, Wang H, Wang Z, He S, Chen S, Liao D, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell. 2012;148:213\u201327.","journal-title":"Cell"},{"key":"1689_CR23","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","volume":"137","author":"YS Cho","year":"2009","unstructured":"Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell. 2009;137:1112\u201323.","journal-title":"Cell"},{"key":"1689_CR24","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.celrep.2016.03.037","volume":"15","author":"TL Aaes","year":"2016","unstructured":"Aaes TL, Kaczmarek A, Delvaeye T, De Craene B, De Koker S, Heyndrickx L, et al. Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity. Cell Rep. 2016;15:274\u201387.","journal-title":"Cell Rep"},{"key":"1689_CR25","doi-asserted-by":"crossref","unstructured":"Snyder AG, Hubbard NW, Messmer MN, Kofman SB, Hagan CE, Orozco SL, et al. Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity. Sci Immunol. 2019;4:eaaw2004.","DOI":"10.1126\/sciimmunol.aaw2004"},{"key":"1689_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.aad0395","volume":"350","author":"N Yatim","year":"2015","unstructured":"Yatim N, Jusforgues-Saklani H, Orozco S, Schulz O, Barreira da Silva R, Reis e Sousa C, et al. RIPK1 and NF-kappaB signaling in dying cells determines cross-priming of CD8(+) T cells. Science. 2015;350:328\u201334.","journal-title":"Science"},{"key":"1689_CR27","doi-asserted-by":"crossref","unstructured":"Chen KS, Manoury-Battais S, Kanaya N, Vogiatzi I, Borges P, Kruize SJ, et al. An inducible RIPK3-driven necroptotic system enhances cancer cell-based immunotherapy and ensures safety. J Clin Invest. 2024;135:e181143.","DOI":"10.1172\/JCI181143"},{"key":"1689_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06801-8","volume":"15","author":"AJ Rucker","year":"2024","unstructured":"Rucker AJ, Park CS, Li QJ, Moseman EA, Chan FK. Necroptosis stimulates interferon-mediated protective anti-tumor immunity. Cell Death Dis. 2024;15:403.","journal-title":"Cell Death Dis"},{"key":"1689_CR29","first-page":"21","volume":"56","author":"KY Lin","year":"1996","unstructured":"Lin KY, Guarnieri FG, Staveley-O\u2019Carroll KF, Levitsky HI, August JT, Pardoll DM, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 1996;56:21\u20136.","journal-title":"Cancer Res"},{"key":"1689_CR30","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","volume":"21","author":"S Bedoui","year":"2020","unstructured":"Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol. 2020;21:678\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1689_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-6-43","volume":"6","author":"A Mullick","year":"2006","unstructured":"Mullick A, Xu Y, Warren R, Koutroumanis M, Guilbault C, Broussau S, et al. The cumate gene-switch: a system for regulated expression in mammalian cells. BMC Biotechnol. 2006;6:43.","journal-title":"BMC Biotechnol"},{"key":"1689_CR32","first-page":"3239","volume":"60","author":"N Mach","year":"2000","unstructured":"Mach N, Gillessen S, Wilson SB, Sheehan C, Mihm M, Dranoff G. Differences in dendritic cells stimulated by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or flt3-ligand. Cancer Res. 2000;60:3239\u201346.","journal-title":"Cancer Res"},{"key":"1689_CR33","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.immuni.2016.08.015","volume":"45","author":"M Guilliams","year":"2016","unstructured":"Guilliams M, Dutertre CA, Scott CL, McGovern N, Sichien D, Chakarov S, et al. Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species. Immunity. 2016;45:669\u201384.","journal-title":"Immunity"},{"key":"1689_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.immuni.2024.01.013","volume":"57","author":"KP Burke","year":"2024","unstructured":"Burke KP, Chaudhri A, Freeman GJ, Sharpe AH. The B7:CD28 family and friends: Unraveling coinhibitory interactions. Immunity. 2024;57:223\u201344.","journal-title":"Immunity"},{"key":"1689_CR35","doi-asserted-by":"publisher","first-page":"15818","DOI":"10.1073\/pnas.2636938100","volume":"100","author":"BM Sullivan","year":"2003","unstructured":"Sullivan BM, Juedes A, Szabo SJ, von Herrath M, Glimcher LH. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci USA. 2003;100:15818\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1689_CR36","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nri1248","volume":"3","author":"O Acuto","year":"2003","unstructured":"Acuto O, Michel F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol. 2003;3:939\u201351.","journal-title":"Nat Rev Immunol"},{"key":"1689_CR37","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41590-022-01324-w","volume":"23","author":"R Wu","year":"2022","unstructured":"Wu R, Ohara RA, Jo S, Liu TT, Ferris ST, Ou F, et al. Mechanisms of CD40-dependent cDC1 licensing beyond costimulation. Nat Immunol. 2022;23:1536\u201350.","journal-title":"Nat Immunol"},{"key":"1689_CR38","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/s41590-023-01517-x","volume":"24","author":"E Gressier","year":"2023","unstructured":"Gressier E, Schulte-Schrepping J, Petrov L, Brumhard S, Stubbemann P, Hiller A, et al. CD4(+) T cell calibration of antigen-presenting cells optimizes antiviral CD8(+) T cell immunity. Nat Immunol. 2023;24:979\u201390.","journal-title":"Nat Immunol"},{"key":"1689_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt3044","volume":"11","author":"U Kantheti","year":"2025","unstructured":"Kantheti U, Forward TS, Lucas ED, Schafer JB, Tamburini PJ, Burchill MA, et al. PD-L1-CD80 interactions are required for intracellular signaling necessary for dendritic cell migration. Sci Adv. 2025;11:eadt3044.","journal-title":"Sci Adv"},{"key":"1689_CR40","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.immuni.2019.11.003","volume":"51","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Lee CK, Lin CH, Gassen RB, Xu X, Huang Z, et al. PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways. Immunity. 2019;51:1059\u201373.e9.","journal-title":"Immunity"},{"key":"1689_CR41","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cell.2019.09.035","volume":"179","author":"CC Brown","year":"2019","unstructured":"Brown CC, Gudjonson H, Pritykin Y, Deep D, Lavallee VP, Mendoza A, et al. Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity. Cell. 2019;179:846\u201363.e24.","journal-title":"Cell"},{"key":"1689_CR42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41590-024-02065-8","volume":"26","author":"M Belabed","year":"2025","unstructured":"Belabed M, Park MD, Blouin CM, Balan S, Moon CY, Freed G, et al. Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer. Nat Immunol. 2025;26:188\u201399.","journal-title":"Nat Immunol"},{"key":"1689_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07616-x","volume":"16","author":"X Hou","year":"2025","unstructured":"Hou X, Chen Y, Carrillo ND, Cryns VL, Anderson RA, Sun J, et al. Phosphoinositide signaling at the cytoskeleton in the regulation of cell dynamics. Cell Death Dis. 2025;16:296.","journal-title":"Cell Death Dis"},{"key":"1689_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.0105-2896.2009.00871.x","volume":"234","author":"P Cheng","year":"2010","unstructured":"Cheng P, Zhou J, Gabrilovich D. Regulation of dendritic cell differentiation and function by Notch and Wnt pathways. Immunol Rev. 2010;234:105\u201319.","journal-title":"Immunol Rev"},{"key":"1689_CR45","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.immuni.2009.03.021","volume":"30","author":"J Zhou","year":"2009","unstructured":"Zhou J, Cheng P, Youn JI, Cotter MJ, Gabrilovich DI. Notch and wingless signaling cooperate in regulation of dendritic cell differentiation. Immunity. 2009;30:845\u201359.","journal-title":"Immunity"},{"key":"1689_CR46","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.immuni.2018.04.008","volume":"48","author":"E Cuadrado","year":"2018","unstructured":"Cuadrado E, van den Biggelaar M, de Kivit S, Chen YY, Slot M, Doubal I, et al. Proteomic Analyses of Human Regulatory T Cells Reveal Adaptations in Signaling Pathways that Protect Cellular Identity. Immunity. 2018;48:1046\u201359.e6.","journal-title":"Immunity"},{"key":"1689_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/science.1259038","volume":"347","author":"M Jovanovic","year":"2015","unstructured":"Jovanovic M, Rooney MS, Mertins P, Przybylski D, Chevrier N, Satija R, et al. Immunogenetics. Dynamic profiling of the protein life cycle in response to pathogens. Science. 2015;347:1259038.","journal-title":"Science"},{"key":"1689_CR48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrg3185","volume":"13","author":"C Vogel","year":"2012","unstructured":"Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012;13:227\u201332.","journal-title":"Nat Rev Genet"},{"key":"1689_CR49","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.immuni.2015.05.018","volume":"42","author":"J Helft","year":"2015","unstructured":"Helft J, Bottcher J, Chakravarty P, Zelenay S, Huotari J, Schraml BU, et al. GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells. Immunity. 2015;42:1197\u2013211.","journal-title":"Immunity"},{"key":"1689_CR50","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.4049\/jimmunol.174.11.6592","volume":"174","author":"SH Naik","year":"2005","unstructured":"Naik SH, Proietto AI, Wilson NS, Dakic A, Schnorrer P, Fuchsberger M, et al. Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol. 2005;174:6592\u20137.","journal-title":"J Immunol"},{"key":"1689_CR51","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1182\/blood.V96.9.3029","volume":"96","author":"K Brasel","year":"2000","unstructured":"Brasel K, De Smedt T, Smith JL, Maliszewski CR. Generation of murine dendritic cells from flt3-ligand\u2013supplemented bone marrow cultures. Blood. 2000;96:3029\u201339.","journal-title":"Blood"},{"key":"1689_CR52","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.immuni.2020.07.008","volume":"53","author":"MA Morrissey","year":"2020","unstructured":"Morrissey MA, Kern N, Vale RD. CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis. Immunity. 2020;53:290\u2013302.e6.","journal-title":"Immunity"},{"key":"1689_CR53","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2017.03.020","volume":"169","author":"YN Gong","year":"2017","unstructured":"Gong YN, Guy C, Olauson H, Becker JU, Yang M, Fitzgerald P, et al. ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences. Cell. 2017;169:286\u2013300.e16.","journal-title":"Cell"},{"key":"1689_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2025.104185","volume":"6","author":"K Hanggi","year":"2025","unstructured":"Hanggi K, Ruffell B. Protocol for specific induction of apoptosis or necroptosis in established murine tumors. STAR Protoc. 2025;6:104185.","journal-title":"STAR Protoc"},{"key":"1689_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adi4191","volume":"9","author":"MP Plebanek","year":"2024","unstructured":"Plebanek MP, Xue Y, Nguyen YV, DeVito NC, Wang X, Holtzhausen A, et al. A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression. Sci Immunol. 2024;9:eadi4191.","journal-title":"Sci Immunol"},{"key":"1689_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04804-6","volume":"9","author":"H Guak","year":"2018","unstructured":"Guak H, Al Habyan S, Ma EH, Aldossary H, Al-Masri M, Won SY, et al. Glycolytic metabolism is essential for CCR7 oligomerization and dendritic cell migration. Nat Commun. 2018;9:2463.","journal-title":"Nat Commun"},{"key":"1689_CR57","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.cmet.2017.08.012","volume":"26","author":"PM Thwe","year":"2017","unstructured":"Thwe PM, Pelgrom LR, Cooper R, Beauchamp S, Reisz JA, D\u2019Alessandro A, et al. Cell-Intrinsic Glycogen Metabolism Supports Early Glycolytic Reprogramming Required for Dendritic Cell Immune Responses. Cell Metab. 2017;26:558\u201367 e5.","journal-title":"Cell Metab"},{"key":"1689_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35615-5","volume":"14","author":"X Lei","year":"2023","unstructured":"Lei X, Khatri I, de Wit T, de Rink I, Nieuwland M, Kerkhoven R, et al. CD4(+) helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment. Nat Commun. 2023;14:217.","journal-title":"Nat Commun"},{"key":"1689_CR59","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41423-024-01133-1","volume":"21","author":"X Lei","year":"2024","unstructured":"Lei X, de Groot DC, Welters MJP, de Wit T, Schrama E, van Eenennaam H, et al. CD4(+) T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors. Cell Mol Immunol. 2024;21:374\u201392.","journal-title":"Cell Mol Immunol"},{"key":"1689_CR60","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng L, Liang H, Xu M, Yang X, Burnette B, Arina A, et al. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. Immunity. 2014;41:843\u201352.","journal-title":"Immunity"},{"key":"1689_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2024.106938","volume":"270","author":"J Busselaar","year":"2024","unstructured":"Busselaar J, Sijbranda M, Borst J. The importance of type I interferon in orchestrating the cytotoxic T-cell response to cancer. Immunol Lett. 2024;270:106938.","journal-title":"Immunol Lett"},{"key":"1689_CR62","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, et al. The Immune Landscape of Cancer. Immunity. 2018;48:812\u201330.e14.","journal-title":"Immunity"},{"key":"1689_CR63","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.1016\/j.cell.2021.09.014","volume":"184","author":"BA Luca","year":"2021","unstructured":"Luca BA, Steen CB, Matusiak M, Azizi A, Varma S, Zhu C, et al. Atlas of clinically distinct cell states and ecosystems across human solid tumors. Cell. 2021;184:5482\u201396.e28.","journal-title":"Cell"},{"key":"1689_CR64","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.immuni.2018.03.004","volume":"48","author":"MD Wellenstein","year":"2018","unstructured":"Wellenstein MD, de Visser KE. Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape. Immunity. 2018;48:399\u2013416.","journal-title":"Immunity"},{"key":"1689_CR65","doi-asserted-by":"crossref","unstructured":"Frijlink E, Bosma DMT, Busselaar J, Battaglia TW, Staal MD, Verbrugge I, et al. PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice. J Clin Invest. 2024;134:e171154.","DOI":"10.1172\/JCI171154"},{"key":"1689_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/srep13875","volume":"5","author":"W Jiang","year":"2015","unstructured":"Jiang W, Hua R, Wei M, Li C, Qiu Z, Yang X, et al. An optimized method for high-titer lentivirus preparations without ultracentrifugation. Sci Rep. 2015;5:13875.","journal-title":"Sci Rep"},{"key":"1689_CR67","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.molimm.2014.07.011","volume":"63","author":"D Vremec","year":"2015","unstructured":"Vremec D, Hansen J, Strasser A, Acha-Orbea H, Zhan Y, O\u2019Keeffe M, et al. Maintaining dendritic cell viability in culture. Mol Immunol. 2015;63:264\u20137.","journal-title":"Mol Immunol"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01689-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01689-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01689-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:03:03Z","timestamp":1788519783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01689-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1689"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01689-7","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All mouse experiments were approved by the animal welfare body of the Leiden University Medical Center (LUMC) and were done in accordance with LUMC and national guidelines for animal experimentation under license number AVD16497.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}